Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × INDUSTRY × Polyps × Clear all

Phase

Status

Completed 18 Unknown 2 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

OTHER 4 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 387 Neoplasms 267 Breast Neoplasms 244 Colorectal Neoplasms 203 Neoplasm Metastasis 165 Ovarian Neoplasms 152 Recurrence 135 Lung Neoplasms 129 Prostatic Neoplasms 127 Pancreatic Neoplasms 122 Squamous Cell Carcinoma of Head and Neck 115 Multiple Myeloma 111 Melanoma 107 Stomach Neoplasms 106 Endometrial Neoplasms 104 Leukemia, Myeloid, Acute 102 Advanced Solid Tumor 99 Triple Negative Breast Neoplasms 87 Advanced Solid Tumors 86 Uterine Cervical Neoplasms 79 Carcinoma, Hepatocellular 79 Lymphoma, Non-Hodgkin 73 Small Cell Lung Carcinoma 70 Lymphoma 66 Carcinoma, Renal Cell 60 Lymphoma, Large B-Cell, Diffuse 59 Leukemia, Lymphocytic, Chronic, B-Cell 59 Lymphoma, Follicular 57 Solid Tumor 56 Head and Neck Neoplasms 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06950385 2026-03-17

SERENTA

Rapamycin Holdings Inc.

Phase 3 Recruiting

Gastrointestinal

Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡